News
The S&P 500 added another 0.1% in early trading after setting an all-time high every day last week. The Dow Jones Industrial ...
U.S. stocks are hanging near their records following a stellar run. The S&P 500 rose another 0.1 per cent Monday after ...
Oppenheimer chief market strategist John Stoltzfus boosted his year-end target to 7,100 from 5,950 in a note to clients on Sunday night, writing that "progress on trade negotiations removes an ...
2h
Zacks Investment Research on MSNIs It Worth Investing in CrowdStrike (CRWD) Based on Wall Street's Bullish Views?The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
Nvidia (NASDAQ: NVDA) has been one of the best-performing stocks in recent years, with its price up more than 1,000% since ...
1h
Zacks Investment Research on MSNHow Much Upside is Left in Kennedy-Wilson (KW)? Wall Street Analysts Think 30.26%Kennedy-Wilson (KW) closed the last trading session at $7.6, gaining 9.2% over the past four weeks, but there could be plenty ...
FOMO Risk Rising: The U.S.–EU trade deal avoided a worst-case tariff scenario and unlocked a wave of cross-Atlantic ...
An Entry Point to Growth & Income The S&P 500 has soared to new heights, driven largely by low-yielding tech giants, pushing ...
While this signals stretched valuations in the market, not all artificial intelligence (AI) stocks joined the frenzy. There ...
3h
24/7 Wall St. on MSN4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return PotentialHere are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
Recently, analysts at EPFR, an ISI Markets company, caused a bit of a stir by publishing the chart above. It shows that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results